ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH EVAN YU
Management of mCRPC using Sipuleucel-T

VIEW ALL mCRPC VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH JACOB BERCHUCK & MARY-ELLEN TAPLIN
Genetic Risk in Prostate Cancer

VIEW ALL PROSTATE CANCER VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH KARIM FIZAZI
ARAMIS Trial in Prostate Cancer: Impact of Darolutamide on Pain and Quality of Life

VIEW ALL nmCRPC VIDEOS

EAU 2019 ANNUAL MEETING

EAU 2019 ANNUAL MEETING

INTERVIEW WITH THOMAS POWLES
Immunotherapy in the Peri-Operative Setting for Bladder Cancer

VIEW ALL BLADDER CANCER VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Featured Videos

#WCE2014 - Does time interval from stone diagnosis to treatment affect outcomes? - Interview

TAIPEI, TAIWAN (UroToday.com) - Introduction and Objectives: Limited resources at publically funded hospitals may demand that definitive surgical intervention for stones be delayed weeks or months, necessitating drainage to stabilize the patient and protect renal function. We sought to analyze the impact of time to treatment on patient morbidity and healthcare resource utilization.

Methods: We reviewed billing records to identify consecutive surgical procedures for stones (shock wave lithotripsy, ureteroscopy, percutaneous nephrolithotomy) performed at our county hospital between January 2011 and December 2013. Clinical outcomes, including need for temporizing measures and unplanned hospital encounters, from diagnosis to treatment were recorded.

Results: A total of 795 patients underwent surgical treatment for stones during the study period. Median time from diagnosis to surgery was 83 days (range 0–1147). A total of 292 patients underwent initial placement of a stent (196) or nephrostomy tube (96), and 47 of these required one or more tube changes prior to treatment. A total of 765 unplanned encounters (emergency department (ED) or clinic visits) were required for 440 patients (55.3%), including 11.6% who required hospital admission. Patients treated > 45 days after initial diagnosis were 12.8 times (95% CI 6.8–24.0, p < 0.001) more likely to have an unplanned clinic visit and 2.5 times (95% CI 1.8–3.6, p < 0.001) more likely to have an ED visit than patients treated within 45 days of diagnosis.

Conclusions: Longer time interval between diagnosis and treatment is associated with increased patient morbidity. Whether this is a consequence of complications of temporizing drainage or is a reflection of differences in patient acuity is currently under investigation.

Source of Funding: None

 
View an interview with Justin Friedlander, one of the authors of this study.

 

Presented by Justin Friedlander,1, 2 Asim Ozayar,2 Shuvro De,2 Nicholas Kavoussi,2 Jodi Antonelli,2 and Margaret Pearle2 at the 32nd World Congress of Endourology & SWL - September 3 - 7, 2014 - Taipei, Taiwan

1Einstein Healthcare Network, Urologic Institute of Southeastern PA, USA
2University of Texas Southwestern Medical Center, USA

 
 
Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe